DOSSIER · 13F Holders · Q2 2026
XTLB

XTL BIOPHARMACEUTICALS LTD SPONSORED ADS

3 institutions still hold XTL BIOPHARMACEUTICALS LTD SPONSORED ADS as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 98386D406·3 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$25K
visible holders
Holders
3
filers reporting
Concentration
67.34%
RHUMBLINE ADVISERS #1
top holder share
AI Holders Summary · Q2 2026

3 institutions reported XTLB in Q2 2026. RHUMBLINE ADVISERS leads at 67.3% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
RHUMBLINE ADVISERS
CIK 0001115418
$17K6K0.00%Q2 2026
02
GAMMA Investing LLC
CIK 0002010235
$8K3K0.00%Q3 2026
03
UBS Group AG
CIK 0001610520
$3411250.00%Q2 2026
Insiders at XTL BIOPHARMACEUTICALS LTD SPONSORED ADS
Weiner Ben-Zion →Weiss Michael S →